Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
TRACON Pharmaceuticals, Inc. (TCON)
OTHER OTC:TCON
RESEARCH TOOLSreports
TRACON Pharmaceuticals (TCON) Ownership - Who Owns TRACON Pharmaceuticals?
701 Followers
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Nov 14, 2023 | Opaleye Management Inc. >10% Owner | xxxxxxxxxxxxx | $1381562 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $10573 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,466,003 | Insider | 129.38% | 2,703,482 | |
| 3,466,003 | Insider | 129.38% | 2,703,482 | |
| 3,466,003 | Insider | 129.38% | 2,703,482 | |
| 3,466,003 | Insider | 129.38% | 2,703,482 | |
| 3,466,003 | Insider | 129.38% | 2,703,482 | |
| 3,466,003 | Insider | 129.38% | 2,703,482 | |
| 3,466,003 | Insider | 129.38% | 2,703,482 | |
| 3,466,003 | Insider | 129.38% | 2,703,482 | |
| 3,466,003 | Insider | 129.38% | 2,703,482 | |
| 3,466,003 | Insider | 129.38% | 2,703,482 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 624,398 | Institution | 23.31% | 487,030 | |
| 200,699 | Institution | 7.49% | 156,545 | |
| 22,638 | Institution | 0.85% | 17,658 | |
| 13,800 | Institution | 0.52% | 10,764 | |
| 4,428 | Institution | 0.17% | 3,454 | |
| 1,275 | Institution | 0.05% | 995 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,139 | Institution | 0.49% | 16,818 |
FAQ
Who Owns TRACON Pharmaceuticals, Inc. (TCON)?
Currently, no data Available
What percentage of TRACON Pharmaceuticals, Inc. (TCON) stock is held by institutional investors?
Currently, no data Available
What percentage of TRACON Pharmaceuticals, Inc. (TCON) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of TRACON Pharmaceuticals, Inc. (TCON)?
David Mott owns the most shares of TRACON Pharmaceuticals, Inc. (TCON).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.